Legend Biotech (LEGN) Receivables (2019 - 2026)
Legend Biotech's Receivables came in at $1.7 million for Q1 2026, up 28.5% from $1.32 million a year earlier but down 87.0% from the prior quarter.
Powered by 
Analysis
Legend Biotech (LEGN) Receivables (2019 - 2026) Analysis & Trends
At the end of FY2025, Legend Biotech's Receivables was $13.1 million, up 82.5% from FY2024.
- Receivables carries a five-year compound annual growth rate of -29.5% (FY2020 to FY2025).
- Going back by year, Receivables was $7.18 million in FY2024 (-92.9%), $100.83 million in FY2023, $1.04 million in FY2022 (-98.0%) and $51.25 million in FY2021 (-31.9%).
- The five-year range for quarterly Receivables is $56,000 (Q1 2023) to $100.83 million (Q4 2023).
- Year-over-year, Receivables increased in three of the last eight quarters, with an average decline of 17.3%.
- The fastest year-over-year change in Receivables over five years came in Q2 2025 (growth of 91.7%), and the weakest in Q1 2023 (a decline of 99.9%).
- Business Quant data shows LEGN's Receivables at $13.1 million (Q4 2025), $2.4 million (Q3 2025) and $28.63 million (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Legend Biotech | 3.43 Bn | -308.34 Mn | 251.50 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.70 Mn |
| Dec 31, 2025 | 13.10 Mn |
| Sep 30, 2025 | 2.40 Mn |
| Jun 30, 2025 | 28.63 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 7.18 Mn |
| Sep 30, 2024 | 2.61 Mn |
| Jun 30, 2024 | 14.93 Mn |
| Mar 31, 2024 | 4.38 Mn |
| Dec 31, 2023 | 100.83 Mn |
| Sep 30, 2023 | 48.35 Mn |
| Jun 30, 2023 | 61.75 Mn |
| Mar 31, 2023 | 56,000.00 |
| Dec 31, 2022 | 1.04 Mn |
| Mar 31, 2022 | 50.45 Mn |
| Dec 31, 2021 | 51.25 Mn |
| Sep 30, 2021 | 1.50 Mn |
| Jun 30, 2021 | 15.00 Mn |
| Dec 31, 2020 | 75.26 Mn |
| Dec 31, 2019 | 31.04 Mn |
API Access
Legend Biotech Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=LEGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "LEGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=LEGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();